Mitochondrial Drugs for Alzheimer Disease

• Egile Nagusiak: Xiongwei Zhu (Egilea), Mark A. Smith (Egilea), Katarzyna A. Gustaw-Rothenberg (Egilea), George Perry (Egilea), Xinglong Wang (Egilea), David J. Bonda (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2009-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Therapeutic strategies for Alzheimer disease (AD) have yet to offer a diseasemodifying effect to stop the debilitating progression of neurodegeneration and cognitive decline. Rather, treatments thus far are limited to agents that slow disease progression without halting it, and although much work to...